Contact
Please use this form to send email to PR contact of this press release:
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
TO:
Please use this form to send email to PR contact of this press release:
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
TO: